| Literature DB >> 33173656 |
Palmina Petruzzo1,2, Christian Seulin1, Jean Kanitakis3, Patrick Feugier4,5, Aram Gazarian6, Lionel Badet1,5, Emmanuel Morelon1,5.
Abstract
The importance of psychosocial aspects in upper extremity transplantation (UET) has been emphasized since the beginning of the vascularized composite allotransplantation era. Herein a long-term UET failure mainly due to psychiatric disorders is reported. A young woman amputated in 2004 (electrocution) underwent bilateral UET in 2007. At the time of transplantation the patient underwent a psychological evaluation, which did not completely consider some traits of her personality. Indeed, she had an anxious personality and a tendency to idealize. The trauma of amputation, the injuries associated with the accident, and the short delay between the accident and the transplantation elicited vindictiveness, entitlement, and impulsivity. Following transplantation, she had a high anxiety level, panic attacks, depression, and hypomanic episodes. She was poorly compliant to the rehabilitation program and the immunosuppressive treatment. She developed 13 acute rejection episodes (reversed by appropriate treatment) but neither clinical signs of chronic rejection nor donor specific antibiodies. She developed many severe complications due to the treatment and the psychiatric disorders. At her request, after many interviews, the allografts were removed in 2018. Pathological examination and an angiography performed post-amputation revealed signs of graft vasculopathy of varying severity, in the absence of clinically overt chronic rejection. This case highlights the need to detect during the initial patients' assessment even mild traits of personality disorders, which could herald psychiatric complications after the transplantation, compromising UET outcomes. It further confirms that skin and vessels are the main targets of the alloimmune response in the UET setting.Entities:
Year: 2020 PMID: 33173656 PMCID: PMC7647659 DOI: 10.1097/GOX.0000000000002905
Source DB: PubMed Journal: Plast Reconstr Surg Glob Open ISSN: 2169-7574
Episodes of AR
| Date of AR Episodes | Banff Grade | Treatment |
|---|---|---|
| March 2007 | II | IV Steroids (3 boluses of 1 g) |
| November 2007 | II | IV Steroids (3 boluses of 1 g) |
| September 2008 | III | ATG (75 mg/d for 6 days) |
| September 2009 | II–III | Increase in oral steroid dose |
| November 2010 | II–III | Campath-1H (20 mg) |
| March 2011 | III Capillary thromboses | Campath-1H (20 mg) |
| March 2012 | III Capillary thromboses | Campath-1H (20 mg) |
| March 2013 | III | Increase in oral steroid dose |
| July 2013 | II–III Capillary thromboses | Autologous adipose mesenchymal cells and steroids (1 mg/kg) |
| October 2014 | III Capillary thromboses | Autologous adipose mesenchymal cells |
| February 2016 | IIII | Increase in oral steroid dose |
| January 2017 | III Capillary thromboses | Increase in oral steroid dose |
| June 2018 | I–II | Steroid and tacrolimus creams |
Post-Tx, post-transplantation; ATG, Antithymocyte globulins.